Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Denmark Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20052
20061
20092
20121
20133
20142
20181
20201
20221
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Unknown status3
Enrolling by invitation1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
Abbott Medical Devices2
AstraZeneca2
Rigshospitalet, Denmark2
Alessandro Doria1
Bayer1
Bjarne Linde Noergaard1
CSL Behring1
ECRI bv1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease21
Myocardial Ischemia5
Cardiovascular Diseases4
Heart Diseases4
Myocardial Infarction4
Stroke4
Angina Pectoris3
Coronary Stenosis3
Kidney Diseases3
Peripheral Arterial Disease3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.